Literature DB >> 10932249

Structural basis for the inhibition of porcine pepsin by Ascaris pepsin inhibitor-3.

K K Ng1, J F Petersen, M M Cherney, C Garen, J J Zalatoris, C Rao-Naik, B M Dunn, M R Martzen, R J Peanasky, M N James.   

Abstract

The three-dimensional structures of pepsin inhibitor-3 (PI-3) from Ascaris suum and of the complex between PI-3 and porcine pepsin at 1. 75 A and 2.45 A resolution, respectively, have revealed the mechanism of aspartic protease inhibition by this unique inhibitor. PI-3 has a new fold consisting of two domains, each comprising an antiparallel beta-sheet flanked by an alpha-helix. In the enzyme-inhibitor complex, the N-terminal beta-strand of PI-3 pairs with one strand of the 'active site flap' (residues 70-82) of pepsin, thus forming an eight-stranded beta-sheet that spans the two proteins. PI-3 has a novel mode of inhibition, using its N-terminal residues to occupy and therefore block the first three binding pockets in pepsin for substrate residues C-terminal to the scissile bond (S1'-S3'). The molecular structure of the pepsin-PI-3 complex suggests new avenues for the rational design of proteinaceous aspartic proteinase inhibitors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10932249     DOI: 10.1038/77950

Source DB:  PubMed          Journal:  Nat Struct Biol        ISSN: 1072-8368


  13 in total

1.  Analysis of crystal structures of aspartic proteinases: on the role of amino acid residues adjacent to the catalytic site of pepsin-like enzymes.

Authors:  N S Andreeva; L D Rumsh
Journal:  Protein Sci       Date:  2001-12       Impact factor: 6.725

Review 2.  Evolutionary families of peptidase inhibitors.

Authors:  Neil D Rawlings; Dominic P Tolle; Alan J Barrett
Journal:  Biochem J       Date:  2004-03-15       Impact factor: 3.857

3.  Predicting functional residues of the Solanum lycopersicum aspartic protease inhibitor (SLAPI) by combining sequence and structural analysis with molecular docking.

Authors:  Yasel Guerra; Pedro A Valiente; Colin Berry; Tirso Pons
Journal:  J Mol Model       Date:  2011-11-20       Impact factor: 1.810

4.  Solution structure of the squash aspartic acid proteinase inhibitor (SQAPI) and mutational analysis of pepsin inhibition.

Authors:  Stephen J Headey; Ursula K Macaskill; Michele A Wright; Jolyon K Claridge; Patrick J B Edwards; Peter C Farley; John T Christeller; William A Laing; Steven M Pascal
Journal:  J Biol Chem       Date:  2010-06-09       Impact factor: 5.157

Review 5.  The many faces of protease-protein inhibitor interaction.

Authors:  Jacek Otlewski; Filip Jelen; Malgorzata Zakrzewska; Arkadiusz Oleksy
Journal:  EMBO J       Date:  2005-03-03       Impact factor: 11.598

6.  The squash aspartic proteinase inhibitor SQAPI is widely present in the cucurbitales, comprises a small multigene family, and is a member of the phytocystatin family.

Authors:  John T Christeller; Peter C Farley; Richelle K Marshall; Ananda Anandan; Michele M Wright; Richard D Newcomb; William A Laing
Journal:  J Mol Evol       Date:  2006-11-10       Impact factor: 2.395

7.  Minimizing carry-over in an online pepsin digestion system used for the H/D exchange mass spectrometric analysis of an IgG1 monoclonal antibody.

Authors:  Ranajoy Majumdar; Prakash Manikwar; John M Hickey; Jayant Arora; C Russell Middaugh; David B Volkin; David D Weis
Journal:  J Am Soc Mass Spectrom       Date:  2012-09-20       Impact factor: 3.109

8.  Mammalian metallopeptidase inhibition at the defense barrier of Ascaris parasite.

Authors:  Laura Sanglas; Francesc X Aviles; Robert Huber; F Xavier Gomis-Rüth; Joan L Arolas
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-28       Impact factor: 11.205

9.  Analysis of binding interactions of pepsin inhibitor-3 to mammalian and malarial aspartic proteases.

Authors:  Rebecca E Moose; José C Clemente; Larry R Jackson; Minh Ngo; Kimberly Wooten; Richard Chang; Antonette Bennett; Sibani Chakraborty; Charles A Yowell; John B Dame; Mavis Agbandje-McKenna; Ben M Dunn
Journal:  Biochemistry       Date:  2007-11-16       Impact factor: 3.162

10.  An aspartyl protease inhibitor orthologue expressed by Parelaphostrongylus tenuis is immunogenic in an atypical host.

Authors:  Michael S Duffy; Nancy MacAfee; Michael D B Burt; Judith A Appleton
Journal:  Clin Diagn Lab Immunol       Date:  2002-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.